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Abstract: Gelatin is a principal excipient used as a binder in the formulation of lyophilized 
orally disintegrating tablets. The current study focuses on exploiting the physicochemical 
properties of gelatin by varying formulation parameters to determine their influence on 
orally disintegrating tablet (ODT) characteristics. Process parameters, namely pH and ionic 
strength of the formulations, and ball milling were investigated to observe their effects on 
excipient characteristics and tablet formation. The properties and characteristics of the 
formulations and tablets which were investigated included: glass transition temperature, 
wettability, porosity, mechanical properties, disintegration time, morphology of the internal 
structure of the freeze-dried tablets, and drug dissolution. The results from the pH study 
revealed that adjusting the pH of the formulation away from the isoelectric point of gelatin, 
resulted in an improvement in tablet disintegration time possibly due to increase in gelatin 
swelling resulting in greater tablet porosity. The results from the ionic strength study 
revealed that the inclusion of sodium chloride influenced tablet porosity, tablet morphology 
and the glass transition temperature of the formulations. Data from the milling study 
showed that milling the excipients influenced formulation characteristics, namely 
wettability and powder porosity. The study concludes that alterations of simple parameters 
such as pH and salt concentration have a significant influence on formulation of ODT. 
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1. Introduction 
Orally disintegrating tablets (ODTs), which are also referred to as orodispersible and fast 
disintegrating tablets, are tablets which when placed in the mouth, disperse/disintegrate rapidly before 
being swallowed, due to the action of saliva [1]. The Food and Drug Administration recommends that 
ODTs be considered as solid oral preparations that disintegrate rapidly in the oral cavity, with an in 
vitro disintegration time of approximately 30 seconds or less, when based on the United States 
Pharmacopeia disintegration test method or alternative [2]. This form of solid dosage form is therefore 
highly applicable for groups of the population who commonly have difficulty in swallowing 
conventional solid dosage forms (e.g. conventional tablets and capsules), such as pediatric and 
geriatric patients [3]. 
A number of technologies have been used to manufacture ODTs including freeze-drying 
(lyophilization), molding and conventional compression methods [4]. More recently new technologies 
such as tablet loading [5], compression of pulverized components [6] and sublimation [7] have also 
been reported. 
However, ODTs manufactured using freeze-drying have been the most successful commercially. 
Tablets manufactured using this technology, generally exhibit rapid disintegration and dissolution due 
to their highly porous nature, which allows penetration of saliva into the matrix of the tablets, resulting 
in disintegration. The freeze-drying process involves the transition of water from liquid to solid during 
freezing, and then solid to vapor during sublimation [8]. A particular advantage of freeze-drying is that 
the solution is frozen such that the final dry product is a network of solid occupying the same volume 
as the original solution, resulting in a light and porous product which is readily soluble [8]. 
Gelatin and mannitol are both excipients which are used in the formulation of freeze-dried ODTs 
[9]. These materials are responsible for forming the highly porous matrix structure of the dosage form. 
Gelatin, a protein, which acts as a glassy amorphous compound, provides structural strength, whilst 
mannitol (a sugar alcohol) provides crystallinity, hardness and elegance [9]. Water is used as a 
manufacturing process media, which induces the porous structure upon sublimation during the freeze-
drying stage [9]. 
Interestingly, studies investigating molecular variations in gelatin configuration have shown that 
various factors such as pH and salt concentration influence its packing and solubility. A pH-swelling 
curve for lime processed gelatin (type B) has been reported [10]. The results showed that adjusting the 
pH away from the isoelectric point resulted in a significant swelling of the material. Subsequently, the 
swelling properties of gelatin could potentially be utilized to increase the porosity of the freeze-dried 
tablet matrix, and could lead to a reduction in disintegration time. Another study investigating the 
solubility of gelatin has shown that it exhibits its lowest solubility at pH 5 (isoelectric point), with 
improvements in solubility above the isoelectric point [11,12]. Other factors that have shown to 
influence gelatin swelling and solubility include the addition of neutral salts and variations in ionic 
strength of the formulation [12,13]. Despite the availability of literature on gelatin behavior, there has 
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been no work reported in exploiting gelatin properties under different conditions in the formulation  
of ODTs. 
Besides varying parameters such as pH and ionic strength that will potentially influence the 
physicochemical properties of gelatin, another factor which has received very little attention is particle 
size reduction. Ball milling is a widely used technique to reduce particle size [14] and has been shown 
to influence the transition of materials from crystalline to amorphous form [15,16]; to change the 
performance of a variety of dosage forms by improving their solubility [17], dissolution [18], and 
bioavailability [19].  
The aim of the current study was to exploit the various process parameters such as adjustment of pH, 
ionic strength of the formulation and ball milling to study their influence on tablet properties with the 
aim of reducing disintegration time without compromising tablet hardness. The formulated tablets used 
in this study consisted of 9% w/w gelatin and 30% w/w (of the dried tablet weight) mannitol, as 
excipients. The choice of formulation was influenced by the preliminary results which showed that the 
above combination exhibited high tablet hardness and long disintegration time (around two minutes). 
2. Experimental Section 
2.1. Materials 
 
Gelatin (type B, 60 and 75 bloom) and mannitol were supplied by Sigma-Aldrich Chemicals (Poole, 
UK). HPLC grade methanol was supplied by Fisher Scientific (Loughborough, UK). Ibuprofen, 
sodium chloride and sodium hydroxide were supplied by Sigma-Aldrich Chemicals (Poole, UK). 
Hydrochloric acid was supplied by Fisher Scientific (Loughborough, UK). All chemicals were used 
without further purification. 
 
2.2. Methods 
 
2.2.1. Preparation of Freeze-Dried Tablets 
 
Gelatin was dissolved in double-distilled water at about 40 °C, followed by the addition of mannitol 
to form a solution. 1.5 g of the resulting solution was dosed into a tablet mould, frozen at –70 °C for a 
minimum of sixty minutes and freeze-dried (ADVANTAGE, Freeze-Dryer, VIRTIS) according to the 
following regime; primary drying for forty eight hours at a shelf temperature of –40 °C, secondary 
drying for ten hours at a shelf temperature of 20 °C and vacuum pressure of 50mTorr. A minimum of 
ten tablets were prepared for each formulation. 
 
2.2.2. Ball Milling 
 
Mixtures of gelatin and mannitol were milled using a planetary micro mill (FRITSCH Pulverisette 7, 
Germany), with 45 mL agate grinding bowls and 10 mm diameter agate balls at room temperature. The 
milling process was performed under various conditions, as shown in Table 1, in order to investigate 
the effect of the milling parameters, i.e., milling time, rotation speed, and ball: powder weight ratio, on 
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the; wettability, porosity of the milled samples and glass transition of the formulations in their frozen 
state prior to freeze-drying. Ultimately the effect of milling on the properties of the freeze-dried tablets, 
namely; disintegration time, porosity, hardness and fracturability were investigated. The weight of the 
gelatin-mannitol mixture was 3 g for all of the milling conditions. The milling parameters were 
determined using MODDE factorial-experimental design software. 
 
Table 1. Ball milling conditions of the various formulations. 
Formulation Milling Time 
(minutes) 
Rotation Speed 
(rpm) 
Ball: Powder 
Weight Ratio 
N1 15 100 5 
N2 60 100 5 
N3 15 400 5 
N4 60 400 5 
N5 15 100 15 
N6 60 100 15 
N7 15 400 15 
N8 60 400 15 
N9 37.5 250 10 
N10 37.5 250 10 
N11 37.5 250 10 
 
2.2.3. Differential Scanning Calorimetry (DSC) 
 
DSC (Pyris Diamond DSC and Intercooler 2P: Perkin Elmer, Wellessey, USA) was used to 
determine the glass transition temperature (Tg) of the formulations in their frozen state (before freeze-
drying). 10–15 mg of the liquid samples were loaded into aluminum pans, cooled to –65 °C at a rate of 
5 °C/min with a nitrogen purge of 20 mL/min, an empty aluminum pan was used as a reference for all 
measurements.  
The resulting thermograms were analyzed by Pyris manager software. Tg values were determined 
from the intersection of relative tangents to the baseline. Three samples/measurements were taken for 
each formulation, and the mean values ± standard error were reported. 
 
2.2.4. Wettability Analysis 
 
The wettability of the milled and non-milled (control formulation) samples were analyzed using the 
Wilhelmy method, to determine their contact angle. A Camtel© (Hertfordshire, UK) QCT-100 surface 
tensiometer was used to determine the contact angle and subsequent wettability of the samples.  
Glass slides measuring 24 × 24 mm in size were covered with 12 × 24 mm double-sided adhesive 
tape. The glass slides were then placed in the various formulations, to coat them. Excess formulation 
was removed by gentle tapping to ensure a uniform coat. Glass slides were then securely attached to 
the microbalance of the apparatus, and during wettability analysis, a glass beaker containing the test 
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liquid (80 mL of double distilled water) was raised and lowered at a rate of 0.200 mm/s, to immerse 
the glass slides. During this period, contact angles were determined automatically at regular intervals. 
Each formulation was analyzed in triplicate for their greatest contact angle, and mean ± standard 
error is reported. The test liquid was replaced for analyzing each formulation. 
A linear relationship between wetting time (wettability) and disintegration time of rapidly 
disintegrating tablets has been reported [20]. Therefore, analysis of the wettability of excipients is a 
useful tool in understanding the performance (disintegration time) of fast disintegrating tablets. 
 
2.2.5. Powder Porosity Analysis 
 
The porosity of the milled and non-milled (control formulation) samples were measured using 
helium pycnometry (MULTIPYCNOMETER, Quantachrome Instruments, Hampshire, UK). 1 mL of 
sample was placed in a suitably sized sample cup and subjected to helium pycnometry, to determine 
the true density of the sample. The true density value was then used in the following equation 
(Equation 1) to determine the porosity of the sample: 
Porosity = (1 – bulk density/true density) × 100%   Equation 1 
Bulk density was determined by considering, the mass and volume of the sample. Three porosity 
measurements were taken for each formulation, and the mean ± standard error is reported. The porosity 
of the samples was expressed as a percentage. 
 
2.2.6. Mechanical Properties of the Tablets 
 
The mechanical properties of the tablets (hardness and fracturability) were investigated with a 
texture analyzer (QTS 25: Brookfield, Essex, UK) equipped with a 25 kg load cell. The instrument was 
calibrated by standard weights of 500 g and 5 kg. The tablets were placed in a holder with a cylindrical 
hole. The hardness was taken as the peak force after 1mm penetration of a 5 mm diameter probe at a 
rate of 6 mm/min. Three measurements were taken for both hardness and fracturability, for each 
formulation, and the mean ± standard error is reported. 
 
2.2.7. Disintegration Time of the Tablets 
 
The disintegration time of the tablets was determined using a USP disintegration tester (Erweka, 
ZT3). 800 mL of double distilled water, which was kept at 37 ± 2 °C, was used as the medium and the 
basket was raised and lowered at a fixed rate of 30 per minute. Three tablets were evaluated from each 
formulation, and the mean values ± standard error is reported. 
 
2.2.8. Tablet Porosity 
 
The porosity of the tablets was measured using helium pycnometry (MULTIPYCNOMETER, 
Quantachrome Instruments, Hampshire, UK). Two freeze-dried tablets were placed in a suitably sized 
sample cup and subjected to helium pycnometry, to determine the true density of the tablets. The true 
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density value was then used in the equation, as reported above (Equation 1), to determine the porosity 
of the tablets.  
Bulk density was determined by considering tablet weight, diameter and thickness. The diameter 
and thickness of the tablets were determined using a screw gauge (LINEAR Farnell). Three porosity 
measurements were taken for each formulation, and the mean values ± standard error is reported. The 
porosity of the tablets is expressed as a percentage. 
 
2.2.9. Statistical Analysis and Factorial-Experimental Design 
 
The effect of milling on the performance and properties of freeze-dried tablets was compared to 
those of the control (non-milled formulation); using one-way analysis of variance (ANOVA) with the 
Dunnett multiple comparisons test. The significant effect of treatment/level of statistical significance 
was judged as being p < 0.05, with a confidence limit of 95%. This statistical analysis test was also 
used for the ionic strength study.  
In terms of factorial-experimental design, the milling factors consisted of; milling time (ranging 
from 15–60 minutes), rotation speed (ranging from 100–400 rpm) and ball:powder weight ratio 
(ranging from 5–15). Eleven formulations were proposed, which underwent different milling 
conditions, according to the three factors, as shown in Table 1. 
The responses measured included excipient properties; wettability, powder porosity and glass 
transition (of the formulations in their frozen state, prior to freeze-drying). The responses measured 
also included tablet properties; disintegration time, porosity, hardness and fracturability.  
Statistical analysis of the dissolution of ibuprofen from tablets prepared from both non-milled and 
milled excipients was performed using the unpaired t-test with Welch correction. This statistical 
analysis test was also used for the pH study. Ibuprofen was used as a model active pharmaceutical 
ingredient (API), as it is a readily available API. Also, the majority of API’s used in freeze-dried 
ODTs are insoluble or poorly soluble in water, and as ibuprofen is poorly soluble in water, it was 
deemed as a suitable model API to use in the dissolution study. 
 
2.2.10. Morphological Examination 
 
The inner structural morphology and pore size of the freeze-dried tablets were examined by 
scanning electron microscopy (SEM, STEREOSCAN 90, Cambridge Instrument). Thin horizontal and 
vertical samples of the tablets were prepared by cutting them with a surgical blade. The samples were 
placed onto double-sided adhesive strips on aluminum stubs and coated with a thin layer of gold using 
a sputter coater (Polaron SC500, Polaron Equipment, Watford, UK) at 20 mA for three minutes (this 
was performed twice for each set of samples) and then examined by the SEM. The acceleration voltage 
(kV) and the magnification can be seen on each micrograph. The pore size of the freeze-dried tablets 
was measured by using the scale which was visible on each micrograph. The average pore size was 
measured by measuring the pore diameter of around 10 randomly selected individual pores, from these 
values the average pore diameter was calculated. 
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2.2.11. Dissolution Study and HPLC Conditions 
 
The dissolution rate of ibuprofen from the two formulations (milled and non-milled tablet 
excipients), was examined using a Caleva 8ST dissolution bath. The two formulations were analyzed 
in triplicate. The dissolution system employed was USP dissolution apparatus 2 (paddle at 50 rpm 
rotation speed), for a test time of 60 minutes. The dissolution medium consisted of 900 mL of pH 7.2 
phosphate buffer at 37 °C. Dissolution samples were filtered through a 0.45 µm Nylon syringe filter, to 
remove undissolved ibuprofen. 10 µL of the samples were analyzed by HPLC (Dionex), with UV 
detection performed at 230 nm, on a Thermo Scientific Hypersil Gold C18 250 × 4.6 mm 5 micron 
column, with methanol:water (80:20) as the mobile phase and a flow rate of 1.00 mL/min.  
3. Results and Discussion 
3.1. Influence of Changes in pH on Tablet Formation 
 
The first phase of the study investigated the influence of changes in pH of formulation solution 
comprising of gelatin and mannitol. Three pH values of 3, 5 and 8 were chosen to determine the effect 
of pH variation below, at and above the isoelectric point of gelatin. The results showed that tablets 
prepared from solutions with pH adjusted to 3 resulted in severely denatured/degraded tablets when 
compared to formulations prepared at pH 5 and 8.  
The instability of the formulation at pH 3, which included the detection of no Tg, can be attributed 
to various reasons including acid hydrolysis of gelatin, maximum stability of gelatin at pH values 
between 5 and 8 and incompatibility of mannitol in strongly acidic solutions [21-23]. The lack of 
intact tablet formation resulted in no further characterization of formulations prepared at pH 3. 
 
3.1.1. Glass Transition and Tablet Mechanical Properties 
 
DSC analysis of the formulation adjusted to pH 8, in its frozen state (prior to freeze-drying), 
indicated that this formulation exhibited a mean onset Tg of –29.1 ± 0.4 °C, whilst the control 
formulation (pH 5) exhibited a mean onset Tg of –29.8 ± 0.5 °C. The results have shown that pH 
adjustment does not have any plasticization effect or reduced the physical stability of the formulations 
in their frozen state (prior to freeze-drying). 
Measurement of hardness of the resultant tablets prepared upon pH adjustment to 8 indicated a 
mean hardness of 60.0 ± 1.7 N, compared to 52.4 ± 8.8 N, the mean hardness of the tablets prepared at 
pH 5. Adjustment of the pH to 8 did not significantly vary the hardness when compared to pH 5  
(p > 0.05). Similar results were obtained for fracturability studies. 
 
3.1.2. Tablet Porosity, SEM and Disintegration Time Analysis 
 
Porosity analysis of the formulation adjusted to pH 8, as shown in Figure 1, indicated that there 
were significant differences between tablet porosity upon adjustment of pH. The mean porosity value 
of formulations prepared at pH 8 was 93.7 ± 0.1%, whilst the formulations prepared at pH 5 exhibited 
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a mean porosity value of 87.7 ± 0.2% (p < 0.0001). The differences in porosity upon pH adjustment of 
the formulation can possibly be due to differences in swelling properties of gelatin upon change in 
pH. Previous studies have shown that increasing the pH above isoelectric point of gelatin resulted in 
greater swelling of strands due to variations in molecular chains of gelatin molecules thereby resulting 
in larger pore sizes within the tablet matrix [24,25]. 
 
Figure 1. The effect of formulation pH on the porosity of the freeze-dried tablets (mean ± 
S.E., n = 3) (* statistically different).  
 
 
 
To further study the differences in porosity, anatomical studies using scanning electron microscopy 
were carried out. SEM analysis of the formulation adjusted to pH 8, as shown in Figure 2a,b, further 
supports the swelling behavior of gelatin upon pH variations. The 2-dimensional porous structure of 
the freeze-dried tablets of the formulation adjusted to pH 8, appeared to exhibit greater average pore 
diameter (100–140 µm) and thinner average pore wall thickness (20 µm) (Figure 2a,b), compared to 
the freeze-dried tablets of the control formulation (average pore diameter of 90 µm, and average pore 
wall thickness of 40 µm), as shown in Figures 3a and 3b. This observation can be attributed to the 
swelling behavior of gelatin at pH 8 [10] that results in the formation of larger pores with thinner 
walls. 
 
 
 
 
 
 
 
 
 
* 
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Figure 2. (a) SEM image of the tablet matrix of the formulation adjusted to pH 8. 
Horizontal Sample. Low Magnification, ×23; (b) SEM image of the tablet matrix of the 
formulation adjusted to pH 8. Horizontal Sample. High Magnification, ×205. 
 
    
(a)                                                                  (b) 
 
Figure 3. (a) SEM image of the tablet matrix of the control formulation. Horizontal 
Sample. Low Magnification, ×22; (b) SEM image of the tablet matrix of the control 
formulation. Horizontal Sample. High Magnification, ×176. 
 
    
(a)                                                                 (b) 
 
Analysis of the disintegration time of the formulation adjusted to pH 8, as shown in Figure 4, 
indicated a mean disintegration time of 54 ± 1.7 s, whereas the formulation prepared at pH 5 exhibited 
a mean disintegration time of 132 ± 25.4 s. Adjustment of pH resulted in the reduction of 
disintegration time by over a half (p < 0.05), as shown in Figure 4. This observation can be attributed 
to two factors. Firstly, porosity and SEM studies revealed that the tablets prepared at pH 8 had higher 
porosity and thinner pore walls which could result in an increase in water uptake and subsequent 
better wetting/dispersibility [26]. Secondly, previously published reports have shown that aqueous 
solubility of gelatin is influenced by variations in pH with values above the isoelectric point of the 
material exhibiting an increase in its solubility [11,12]. 
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Figure 4. The effect of formulation pH on the disintegration time of the freeze-dried 
tablets (mean ± S.E., n = 3) (* statistically different). 
 
 
 
3.2. Influence of Ionic Strength 
 
To investigate the influence of ionic strength, various ratios of sodium chloride were incorporated 
in the formulation with gelatin and mannitol. The results revealed that sodium chloride had a 
concentration dependant influence. Formulations comprising of a 1:40 molar ratio of gelatin:sodium 
chloride resulted in a collapse of the final product with no tablet formation. Lower molar ratios (1:5, 
1:10, 1:20 and 1:30) produced intact tablets and were characterized further for mechanical as well as 
thermal properties. 
 
3.2.1. Glass Transition and Tablet Mechanical Properties Analysis 
 
DSC analyses of formulations with 1:5–1:30 molar ratios of gelatin:sodium chloride, as shown in 
Table 2, indicated mean onset Tg values comparable to the control formulation. The mean onset Tg 
values were –29.3 ± 0.1 °C, –30.5 ± 0.1 °C, –31.2 ± 0.2 °C and –31.7 ± 0.2°C, for 1:5, 1:10, 1:20 and 
1:30 ratios, respectively, whilst the control formulation exhibited a mean onset Tg value of  
–29.8 ± 0.5 °C. Statistical analysis of the results indicated that the formulations consisting of 
gelatin:sodium chloride in molar ratios of 1:20 and 1:30, exhibited mean onset Tg values which were 
significantly different (p < 0.01) from the control formulation.  
 
 
 
 
 
* 
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Table 2. Glass transition data of the formulations consisting of various ratios of 
gelatin:sodium chloride. 
Formulation Mean Onset Tg (°C) Standard Error 
Control –29.8 0.5 
1:5 –29.3 0.1 
1:10 –30.5 0.1 
1:20 –31.2 0.2 
1:30 –31.7 0.2 
These results are in coherence with previous research investigating the effect of cations and anions 
of various electrolytes on the glass transition temperature of frozen solutions of excipients commonly 
used in freeze-drying, resulting in a decrease in glass transition temperature upon increasing ion 
concentration [27]. Formulations consisting of 1:20 and 1:30 gelatin:sodium chloride molar ratios, did 
exhibit significantly different mean onset Tg values relative to the control formulation (p < 0.01). 
However, as the difference was only around 2 °C, the structural collapse/shrinkage seen with the 
tablets of the formulation consisting of a gelatin:sodium chloride molar ratio of 1:40 was considered a 
physical rather than a thermal stability issue.  
The inclusion of sodium chloride in the formulations with gelatin:sodium chloride molar ratios of 
1:5–1:30 did not result in a significant increase in tablet hardness when compared to the control  
(p > 0.05), as shown in Table 3. Formulations with gelatin:sodium chloride molar ratios of 1:5, 1:10, 
1:20 and 1:30, exhibited hardness values of 63.6 ± 5.6 N, 63.2 ± 8.0 N, 70.1 ± 2.1 N and 67.8 ± 8.3 N, 
respectively, whilst the control formulation had a mean value of 52.4 ± 8.8 N.  
 
Table 3. Tablet hardness data of the formulations consisting of various ratios of 
gelatin:sodium chloride. 
Formulation Mean Tablet Hardness (N) Standard Error 
Control 52.4 8.8 
1:5 63.6 5.6 
1:10 63.2 8.0 
1:20 70.1 2.1 
1:30 67.8 8.3 
 
Analysis of the fracturability of the tablets of formulations with gelatin:sodium chloride molar 
ratios of 1:5–1:30 indicated that there was no statistical difference in the fracturability values of the 
various ratios of sodium chloride when compared to the control.  
 
3.2.2. Tablet Porosity, SEM and Disintegration Time Analysis 
 
The inclusion of sodium chloride in the formulations resulted in differences in porosity of the 
tablets. Statistical analysis of the results indicated that the formulations consisting of gelatin:sodium 
chloride molar ratios of 1:5, 1:20 and 1:30, showed tablet porosities which were statistically 
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significant (p < 0.01), when compared to the tablet porosity of the control formulation. There 
appeared to be a general trend that increasing the molar ratio of gelatin:sodium chloride from 1:5 to 
1:20, produced a general increase in tablet porosity (1:5, 1:10 and 1:20, exhibited tablet porosity 
values of 88.70 ± 0.08%, 87.70 ± 0.08% and 89.50 ± 0.10%, respectively). The differences in porosity 
upon inclusion of sodium chloride can potentially be attributed to the differences in swelling behavior 
of gelatin in the presence of monovalent ions. Previous research has highlighted that the presence of 
sodium chloride had a bearing on the cross-linking of gelatin strands [28]. It is possible that inclusion 
of sodium chloride reduced the cross-linking during gelation which subsequently influenced  
tablet porosity.  
These results were further confirmed by SEM. SEM micrographs showed that the inclusion of 
sodium chloride in the formulations produced porous structures which generally exhibited the 
formation of larger pores and thinner pore walls (Figure 5a,b), compared to the porous structure of the 
control formulation (Figure 3a,b). 
 
Figure 5. (a) SEM image of the tablet matrix of the 1:30 gelatin:soluble salt molar ratio 
formulation. Vertical Sample. Low Magnification, ×25; (b) SEM image of the tablet 
matrix of the 1:30 gelatin:soluble salt molar ratio formulation. Vertical Sample. High 
Magnification, ×205. 
    
(a)                                                                  (b) 
Horizontal sections of the tablets with gelatin:sodium chloride molar ratios of 1:10, 1:20 and 1:30, 
revealed average pore diameters of 100, 210 and 120 µm, respectively. Interestingly, tablets with a 
1:20 gelatin:sodium chloride molar ratio, exhibited the greatest tablet porosity and shortest 
disintegration time of the four gelatin-soluble salt formulations. SEM analysis of the tablets revealed 
that increasing gelatin:soluble salt molar ratio appeared to increase disruption/damage to the porous 
matrix structures. The formulation with gelatin:sodium chloride molar ratio of 1:30, in particular, 
exhibited structural instability (as it appeared that pores had collapsed, forming cavities in the matrix) 
as shown in Figure 5a,b. This was likely due to the higher gelatin:soluble salt molar ratio, which 
appeared to weaken the structure, which led to the collapse of pores. 
Analysis of the tablet disintegration times of formulations with gelatin:sodium chloride molar 
ratios of 1:5–1:30, showed that the inclusion of sodium chloride in the formulations with 
gelatin:sodium chloride molar ratios of 1:10 (126.7 ± 4.0 s) and 1:20 (102.3 ± 10.1 s), did not produce 
a significant reduction in disintegration time compared to the control formulation (132.0 ± 25.6 s 
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mean disintegration time) (p > 0.05). The formulation with a gelatin:sodium chloride molar ratio of 
1:5 produced a disintegration time (134.7 ± 12.0 s) comparable to the control formulation.  
 
3.3. Milling Study 
 
Ball milling has several pharmaceutical applications, which rely on a number of milling 
factors/parameters, such as; milling time, number of milling balls and milling jar volume, to fulfill 
their applications. These milling factors/parameters have a large range of operation, for e.g. milling 
time can range from a few minutes to several hours, thus making the possible number of milled 
sample formulations very large. Hence, factorial-experimental design software was used in order to 
propose a more suitable/manageable number of formulations (as shown in Table 1), which underwent 
various milling conditions based on three parameters; milling time, rotation speed and ball:powder 
weight ratio. 
 
3.3.1. Wettability Analysis 
 
The wettability analysis results are shown in Figure 6. Formulations N7 (milling conditions; 
milling time of 15 minutes, at a rotation speed of 400 rpm, with a ball:powder weight ratio of 15) and 
N11 (milling conditions; milling time of 37.5 minutes, at a rotation speed of 250 rpm, with a 
ball:powder weight ratio of 10) showed the lowest contact angles, 94.0 ± 0.3° and 94.1 ± 1.0° 
respectively, and thus the greatest wettability (p < 0.05), whilst the control formulation exhibited a 
contact angle of 120.7 ± 11.0°. Milling is regularly used for the reduction of particle size [16], the 
observed improvement in wettability as a result of ball milling, can be attributed to a reduction in 
particle size and subsequent increase in surface area of the formulations [29]. 
 
Figure 6. Analysis of the wettability of the milled formulations, expressed through their 
determined contact angle (mean ± S.E., n = 3) (* statistically different).  
 
 
 
* * 
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3.3.2. Powder Porosity Analysis 
 
A significant variation in powder porosity between the formulations was recorded, as some of the 
mixtures exhibited greater porosity than the control (non-milled, 62.1 ± 0.3%), whilst others showed 
lower porosity. Formulation N8 showed the greatest porosity of 69.55 ± 0.1%, whilst formulation N6 
produced the lowest value of 49.19 ± 0.2%. The porosity of the studied formulations is associated 
with their bulk density [30]. Therefore, as porosity varies between the formulations, so do their bulk 
density, which is related to the way in which the particles of the formulations are packed, during 
sample porosity analysis [30]. As milling is associated with particle size reduction, the various milling 
conditions are expected to produce a range of differing particle sizes. It is therefore expected that the 
way these particles pack during porosity analysis varies greatly, which results in differences in inter-
particulate void spaces and subsequent variation in porosity between the formulations. All eleven of 
the formulations exhibited statistical significance, which indicates that ball milling has a significant 
effect on the porosity of the powders. Formulation N10 had a p value of <0.05, whilst all the other 
formulations had a p value of <0.01. 
 
3.3.3. Glass Transition and Tablet Mechanical Properties Analysis 
 
DSC analysis of freeze-dried products is essential in order to fully appreciate and understand 
critical formulation properties such as the collapse temperature of the formulation [31]. The 
macroscopic collapse temperature of a formulation is defined as the temperature above which the 
freeze-dried product loses macroscopic structure and collapses during freeze-drying [32]. The 
macroscopic collapse temperature is closely related to the glass transition temperature of the 
formulation in its frozen state [33]. Therefore, in order to produce an acceptable freeze-dried product, 
it is always required to freeze dry a formulation at a temperature lower than the macroscopic collapse 
temperature [34,35]. 
Six of the eleven formulations exhibited glass transition temperatures which were considered not 
statistically significant (p > 0.05), when compared to the mean glass transition temperature of the 
control (non-milled) formulation. It can therefore be concluded that ball milling does not adversely 
affect the physical stability of the formulations in their frozen state or induce a plasticization effect, as 
comparable glass transition temperatures were observed.  
All eleven of the formulations produced tablet hardness values which were not statistically 
significant (p > 0.05), when compared to the value of the control (non-milled) formulation  
(62.2 ± 3.8 N). Formulation N5 had the tablet hardness value of 55.0 ± 5.0 N, whilst formulation N10 
produced the tablets which had hardness of 65.3 ± 1.0 N. 
Similar results were obtained for fracturability analysis as no significant differences were observed 
when compared to the non-milled control formulation. 
 
3.3.4. Tablet Porosity, SEM and Disintegration Time Analysis 
 
Tablet porosity is a critical property of ODTs, as highly porous tablets allow the rapid penetration 
of saliva into the tablet, which results in rapid oral disintegration. Tablet porosity significantly impacts 
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the initial wetting and dispersion of active pharmaceutical ingredients [26]. It is therefore advisable to 
make tablets as porous as possible in order to achieve rapid disintegration. However, it is important to 
note that the physical/mechanical properties of the tablets such as hardness, should be maintained 
[26]. In general it is considered that increasing tablet porosity leads to an increase in water uptake and 
subsequent better wetting/dispersibility of active pharmaceutical ingredients [26], and consequently 
tablets exhibit shorter disintegration times. 
The control formulation had porosity of 93.4 ± 0.4%. Formulation N6 produced tablets with the 
highest porosity of 94.4 ± 0.3%, whilst formulation N5 resulted in tablets with the lowest porosity of 
92.9 ± 0.1%.  
All studied formulations exhibited tablet porosities which were not statistically significant  
(p > 0.05), when compared to the tablet porosity of the control formulation.  
These data were further confirmed with the SEM analysis as no microscopic differences were 
observed between milled and non-milled formulations. 
The disintegration time was slightly different between the formulations. The control (non-milled) 
had a mean disintegration time of 23 ± 1 s. Tablets from formulation N5 exhibited the greatest 
disintegration time of 28 ± 2 s, whilst formulations N2, N10 and N11 all had the shortest 
disintegration time of 21 s.  
 
3.3.5. Dissolution Study Analysis 
 
Figure 7 illustrates the mean dissolution results for ibuprofen tablets, prepared from non-milled and 
milled tablet excipients. Although the time required for 80% ibuprofen dissolution from the tablets 
prepared from non-milled and milled materials, were 20 and 10 minutes, respectively, statistical 
analysis of the results indicated that there was no significant difference (p > 0.05) in the dissolution 
behavior of ibuprofen from the two tablet formulations. The results have therefore shown that milling 
the excipients did not influence ibuprofen dissolution from the lyophilized ODTs.        
Figure 7. Dissolution profile of ibuprofen from lyophilized ODTs, prepared from non-
milled and milled tablet excipients (mean ± S.E., n = 3).  
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Tablet porosity and disintegration time are both critical properties in determining active 
pharmaceutical ingredient dissolution, as tablet porosity in particular, significantly impacts the initial 
wetting and dispersion of active pharmaceutical ingredients [26]. Initial results from this milling 
study, indicated that ball milling did not significantly affect tablet porosity and tablet disintegration 
time, when compared with tablets prepared from non-milled excipients. Therefore, comparable 
dissolution profiles of ibuprofen from tablets prepared from non-milled and milled materials  
was expected. 
4. Conclusions 
The study has shown that process parameters such as pH adjustment can have a significant 
influence on the disintegration time of gelatin based orally disintegrating tablets. The reduction in 
disintegration time did not compromise tablet hardness, which is a key parameter to measure ODT 
performance. The reduction in disintegration time can be attributed to an increase in tablet porosity, 
which allows the more rapid penetration of saliva or disintegrating medium into the tablet matrix, and 
an increase in gelatin solubility. The inclusion of sodium chloride in the formulations, to modify the 
ionic strength of the formulations, had an effect on tablet porosity and the glass transition of the 
formulations. However, inclusion of sodium ions is concentration dependent, with tablets comprising 
of higher salt concentration resulting in structural collapse/shrinkage. The study has also shown that 
ball milling influences formulation characteristics, such as powder porosity, and improves  
powder wettability. 
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